Skip to main content
Premium Trial:

Request an Annual Quote

Cellgen, Genomics Testing Cooperative Form Cancer Companion Diagnostic Alliance

NEW YORK (GenomeWeb) — Cellgen Diagnostics said today that it has partnered with molecular testing firm Genomic Testing Cooperative (GTC) to offer companion diagnostic development services for cancer immunotherapy developers.

Under the terms of the deal, the companies will combine Cellgen's cartridge assay-based molecular diagnostics platform with GTC's biomarker discovery technologies to create a service for biomarker discovery and validation, as well as in vitro diagnostic companion assay development, for pharmaceutical industry customers.

According to Cellgen, its so-called Immune Panel assays enable patient stratification and therapeutic response monitoring, while GTC's technologies can be used to profile the tumor microenvironment to create patient phenotypic profiles.

The companies — both of which are based in Irvine, California — intend to first focus on next-generation sequencing applications in early-stage clinical programs. Additional terms were not disclosed.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.